Multimodal In Vivo Imaging of Tumorigenesis and Response to Chemotherapy in a Transgenic Mouse Model of Mammary Cancer

Jean-Louis Alberini, Raphaël Boisgard, Stéphanie Guillermet, Karine Siquier, Benoît Jego, Benoît Thézé, Saik Urien, Keyvan Rezaï, Emmanuelle Menet, Renaud Maroy, Frédéric Dollé, Bertrand Kühnast (+1 others)
2015 Molecular Imaging and Biology  
Purpose: Transgenic mice expressing the polyoma middle T oncoprotein (PyMT) in the mammary epithelium were explored by multimodal imaging to monitor longitudinally spontaneous tumor growth and response to chemotherapy. Procedures: Positron emission tomography (PET) with 2-deoxy-2-[ 18 F]fluoro-D-glucose ([ 18 F]FDG) and 3'-deoxy-3'-[ 18 F]fluorothymidine ([ 18 F]FLT), single photon emission tomography (SPECT) with [ 99m Tc]TcO 4 ([ 99m Tc]TEC), X-ray computed tomography, and fluorescent
more » ... endomicroscopy (FCE) images were acquired during tumor progression in female PyMT mice. Imaging with [ 18 F]FDG and [ 99m Tc]TEC was also performed in untreated, doxorubicin-treated, and docetaxel-treated PyMT mice. Total tumor volumes were quantified. Tumors were collected and macroscopic and histological examinations were performed. Results: All PyMT mice developed multifocal tumors of the mammary epithelium that became palpable at 8 weeks of age (W8). Computed tomography (CT) detected tumors at W14, while a clear tumoral uptake of [ 99m Tc]TEC and [ 18 F]FDG was present as early as W6 and W8, respectively. No contrast between mammary tumors and surrounding tissue was observed at any stage with [ 18 F]FLT. FCE detected an angiogenic switch at W10. Lung metastases were not clearly evidenced by imaging. Doxorubicin and docetaxel treatments delayed tumor growth, as shown by [ 18 F]FDG and [ 99m Tc]TEC, but tumor growth resumed upon treatment discontinuation. Tumor growth fitted an exponential model with time constant rates of 0.315, 0.145, and Jean-Louis Alberini and Raphaël Boisgard contributed equally to this work. Electronic supplementary material The online version of this article (0.212 week −1 in untreated, doxorubicin, and docetaxel groups, respectively. Conclusions: Molecular imaging of mammary tumors in PyMT is precocious, precise, and predictive. [ 18 F]FDG-PET and [ 99m Tc]TEC SPECT monitor tumor response to chemotherapy.
doi:10.1007/s11307-015-0916-7 pmid:26630973 pmcid:PMC4927598 fatcat:ouvkxywm3vf43l2s5yhs32ils4